‘The focus of the Symrise white biotechnology project is on macrocyclic musk compounds, which are more readily biodegradable and are highly prized by the fragrance industry for their properties. We’re trying to develop a biotech production process at a competitive cost without using fossil resources, says Dr. Panten from Symrise. “But the natural biosynthesis mechanism is utterly unknown – we’re entering absolute terra incognita. Right now we’re working on using our modern methods of molecular biology to clarify the metabolic pathways in natural producers and on translating these pathways into biotech processes.” Dr. Panten’s team is not working in isolation on this project, but is instead cooperating with a top-class, innovative network composed of the following four orking groups: a team led by Dr. Jens Schrader, a professor at the Karl-Winnacker Institute (DECHEMA), Dr. Gerold Barth, a professor at the Technische Universität Dresden, enzyme specialists from c-Lecta, a young biotech company from Leipzig;and Dr. Wolf-Dieter Fessner and Dr. Harald Kolmar, both professors at the Clemens Schöpf Institute of the Technische Universität Darmstadt. From a pdf on white biotechnology available on symrises website.